CN110554188A - 一种佐剂吸附组分疫苗含量的检测方法 - Google Patents
一种佐剂吸附组分疫苗含量的检测方法 Download PDFInfo
- Publication number
- CN110554188A CN110554188A CN201911008908.6A CN201911008908A CN110554188A CN 110554188 A CN110554188 A CN 110554188A CN 201911008908 A CN201911008908 A CN 201911008908A CN 110554188 A CN110554188 A CN 110554188A
- Authority
- CN
- China
- Prior art keywords
- vaccine
- solution
- standard curve
- content
- tween
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229960005486 vaccine Drugs 0.000 title claims abstract description 58
- 238000000034 method Methods 0.000 title claims abstract description 33
- 239000002671 adjuvant Substances 0.000 title claims abstract description 22
- 238000001179 sorption measurement Methods 0.000 title claims abstract description 16
- 238000001514 detection method Methods 0.000 claims abstract description 35
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims abstract description 29
- 229920000053 polysorbate 80 Polymers 0.000 claims abstract description 29
- 238000003795 desorption Methods 0.000 claims abstract description 3
- 239000000243 solution Substances 0.000 claims description 56
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 42
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 42
- 150000004676 glycans Chemical class 0.000 claims description 41
- 229920001282 polysaccharide Polymers 0.000 claims description 41
- 239000005017 polysaccharide Substances 0.000 claims description 41
- 239000012224 working solution Substances 0.000 claims description 16
- 229940031999 pneumococcal conjugate vaccine Drugs 0.000 claims description 11
- 238000002156 mixing Methods 0.000 claims description 9
- 239000003085 diluting agent Substances 0.000 claims description 8
- 210000002966 serum Anatomy 0.000 claims description 7
- 239000000126 substance Substances 0.000 claims description 7
- 239000003153 chemical reaction reagent Substances 0.000 claims description 6
- 238000007865 diluting Methods 0.000 claims description 6
- 238000012360 testing method Methods 0.000 claims description 5
- 239000002253 acid Substances 0.000 claims description 4
- 239000003513 alkali Substances 0.000 claims description 3
- 238000010998 test method Methods 0.000 claims description 3
- 230000003113 alkalizing effect Effects 0.000 claims description 2
- 230000003472 neutralizing effect Effects 0.000 claims description 2
- 239000003381 stabilizer Substances 0.000 claims description 2
- 229940124931 vaccine adjuvant Drugs 0.000 claims description 2
- 229940124856 vaccine component Drugs 0.000 claims description 2
- 230000035945 sensitivity Effects 0.000 abstract description 8
- 239000000427 antigen Substances 0.000 description 6
- 102000036639 antigens Human genes 0.000 description 6
- 108091007433 antigens Proteins 0.000 description 6
- 238000011088 calibration curve Methods 0.000 description 4
- 239000012488 sample solution Substances 0.000 description 4
- 238000012216 screening Methods 0.000 description 4
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 4
- 238000004879 turbidimetry Methods 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 3
- 230000031700 light absorption Effects 0.000 description 3
- 238000012417 linear regression Methods 0.000 description 3
- 229920000136 polysorbate Polymers 0.000 description 3
- 108010060123 Conjugate Vaccines Proteins 0.000 description 2
- 238000002965 ELISA Methods 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- SQVRNKJHWKZAKO-UHFFFAOYSA-N beta-N-Acetyl-D-neuraminic acid Natural products CC(=O)NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO SQVRNKJHWKZAKO-UHFFFAOYSA-N 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 229940031670 conjugate vaccine Drugs 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 238000013508 migration Methods 0.000 description 2
- 230000005012 migration Effects 0.000 description 2
- 229940031348 multivalent vaccine Drugs 0.000 description 2
- 238000005457 optimization Methods 0.000 description 2
- 229940031937 polysaccharide vaccine Drugs 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000003908 quality control method Methods 0.000 description 2
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- SQVRNKJHWKZAKO-OQPLDHBCSA-N sialic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)OC1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-OQPLDHBCSA-N 0.000 description 2
- 239000001384 succinic acid Substances 0.000 description 2
- 108010041986 DNA Vaccines Proteins 0.000 description 1
- 229940021995 DNA vaccine Drugs 0.000 description 1
- 108010008038 Synthetic Vaccines Proteins 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- XHMJOUIAFHJHBW-CBPJZXOFSA-N [(2r,3s,4r,5s)-5-amino-3,4,6-trihydroxyoxan-2-yl]methyl dihydrogen phosphate Chemical compound N[C@@H]1C(O)O[C@H](COP(O)(O)=O)[C@@H](O)[C@@H]1O XHMJOUIAFHJHBW-CBPJZXOFSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000000240 adjuvant effect Effects 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- ILRRQNADMUWWFW-UHFFFAOYSA-K aluminium phosphate Chemical compound O1[Al]2OP1(=O)O2 ILRRQNADMUWWFW-UHFFFAOYSA-K 0.000 description 1
- 229940103272 aluminum potassium sulfate Drugs 0.000 description 1
- 238000005349 anion exchange Methods 0.000 description 1
- 238000005571 anion exchange chromatography Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 230000000984 immunochemical effect Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- GRLPQNLYRHEGIJ-UHFFFAOYSA-J potassium aluminium sulfate Chemical compound [Al+3].[K+].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O GRLPQNLYRHEGIJ-UHFFFAOYSA-J 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 229940124551 recombinant vaccine Drugs 0.000 description 1
- 238000003118 sandwich ELISA Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229940126580 vector vaccine Drugs 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
- G01N33/56944—Streptococcus
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911008908.6A CN110554188A (zh) | 2019-10-23 | 2019-10-23 | 一种佐剂吸附组分疫苗含量的检测方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911008908.6A CN110554188A (zh) | 2019-10-23 | 2019-10-23 | 一种佐剂吸附组分疫苗含量的检测方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110554188A true CN110554188A (zh) | 2019-12-10 |
Family
ID=68743214
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201911008908.6A Pending CN110554188A (zh) | 2019-10-23 | 2019-10-23 | 一种佐剂吸附组分疫苗含量的检测方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110554188A (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111308071A (zh) * | 2020-03-13 | 2020-06-19 | 长春生物制品研究所有限责任公司 | 解吸附铝盐吸附型疫苗中的抗原的解吸附剂及抗原含量检测方法 |
CN111812313A (zh) * | 2020-06-22 | 2020-10-23 | 北京生物制品研究所有限责任公司 | 铝佐剂吸附型新型冠状病毒灭活疫苗中抗原的解离方法 |
CN111840540A (zh) * | 2020-08-04 | 2020-10-30 | 华北制药金坦生物技术股份有限公司 | 一种乙肝疫苗的解析方法 |
Citations (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040033545A1 (en) * | 2000-01-07 | 2004-02-19 | Dougherty Cristy S. | Competitive enzyme immunoassay for assessing total antigen content of aluminum-adsorbed antigens |
CN102809656A (zh) * | 2012-08-26 | 2012-12-05 | 云南沃森生物技术股份有限公司 | 一种脑膜炎球菌多糖结合疫苗成品各群游离多糖含量的测定方法 |
CN102809655A (zh) * | 2012-08-26 | 2012-12-05 | 玉溪沃森生物技术有限公司 | 一种脑膜炎球菌多糖结合疫苗成品各群多糖含量的测定方法 |
US20130196352A1 (en) * | 2010-09-04 | 2013-08-01 | Novartis Ag | Bactericidal antibody assays to assess immunogenicity and potency of meningococcal capsular saccharide vaccines |
CN103471902A (zh) * | 2013-09-22 | 2013-12-25 | 北京智飞绿竹生物制药有限公司 | 一种解吸附方法及其应用 |
CN104634959A (zh) * | 2013-11-08 | 2015-05-20 | 丽珠集团疫苗工程股份有限公司 | 一种处理液以及采用其测定铝盐吸附型疫苗中抗原含量的方法 |
CN106018832A (zh) * | 2016-07-16 | 2016-10-12 | 北京智飞绿竹生物制药有限公司 | 一种多价肺炎球菌结合疫苗各型特异性糖含量的检测方法 |
CN106706924A (zh) * | 2016-12-08 | 2017-05-24 | 申联生物医药(上海)股份有限公司 | 一种油佐剂疫苗的竞争elisa定性定量检测方法 |
CN106771189A (zh) * | 2016-12-08 | 2017-05-31 | 申联生物医药(上海)股份有限公司 | 一种油佐剂疫苗的快速定性定量检测方法 |
CN106822884A (zh) * | 2016-12-28 | 2017-06-13 | 北京民海生物科技有限公司 | 一种多价肺炎球菌荚膜多糖结合疫苗的制备方法 |
CN107064492A (zh) * | 2016-12-08 | 2017-08-18 | 申联生物医药(上海)股份有限公司 | 一种油佐剂疫苗的快速定性定量检测方法 |
CN108226480A (zh) * | 2017-12-22 | 2018-06-29 | 北京民海生物科技有限公司 | 测定铝盐吸附型DTap-IPV联合疫苗中D-抗原含量的方法 |
-
2019
- 2019-10-23 CN CN201911008908.6A patent/CN110554188A/zh active Pending
Patent Citations (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040033545A1 (en) * | 2000-01-07 | 2004-02-19 | Dougherty Cristy S. | Competitive enzyme immunoassay for assessing total antigen content of aluminum-adsorbed antigens |
US20130196352A1 (en) * | 2010-09-04 | 2013-08-01 | Novartis Ag | Bactericidal antibody assays to assess immunogenicity and potency of meningococcal capsular saccharide vaccines |
CN102809656A (zh) * | 2012-08-26 | 2012-12-05 | 云南沃森生物技术股份有限公司 | 一种脑膜炎球菌多糖结合疫苗成品各群游离多糖含量的测定方法 |
CN102809655A (zh) * | 2012-08-26 | 2012-12-05 | 玉溪沃森生物技术有限公司 | 一种脑膜炎球菌多糖结合疫苗成品各群多糖含量的测定方法 |
CN103471902A (zh) * | 2013-09-22 | 2013-12-25 | 北京智飞绿竹生物制药有限公司 | 一种解吸附方法及其应用 |
CN104634959A (zh) * | 2013-11-08 | 2015-05-20 | 丽珠集团疫苗工程股份有限公司 | 一种处理液以及采用其测定铝盐吸附型疫苗中抗原含量的方法 |
CN106018832A (zh) * | 2016-07-16 | 2016-10-12 | 北京智飞绿竹生物制药有限公司 | 一种多价肺炎球菌结合疫苗各型特异性糖含量的检测方法 |
CN106706924A (zh) * | 2016-12-08 | 2017-05-24 | 申联生物医药(上海)股份有限公司 | 一种油佐剂疫苗的竞争elisa定性定量检测方法 |
CN106771189A (zh) * | 2016-12-08 | 2017-05-31 | 申联生物医药(上海)股份有限公司 | 一种油佐剂疫苗的快速定性定量检测方法 |
CN107064492A (zh) * | 2016-12-08 | 2017-08-18 | 申联生物医药(上海)股份有限公司 | 一种油佐剂疫苗的快速定性定量检测方法 |
CN106822884A (zh) * | 2016-12-28 | 2017-06-13 | 北京民海生物科技有限公司 | 一种多价肺炎球菌荚膜多糖结合疫苗的制备方法 |
CN108226480A (zh) * | 2017-12-22 | 2018-06-29 | 北京民海生物科技有限公司 | 测定铝盐吸附型DTap-IPV联合疫苗中D-抗原含量的方法 |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111308071A (zh) * | 2020-03-13 | 2020-06-19 | 长春生物制品研究所有限责任公司 | 解吸附铝盐吸附型疫苗中的抗原的解吸附剂及抗原含量检测方法 |
CN111308071B (zh) * | 2020-03-13 | 2021-06-18 | 长春生物制品研究所有限责任公司 | 解吸附铝盐吸附型疫苗中的抗原的解吸附剂及抗原含量检测方法 |
CN111812313A (zh) * | 2020-06-22 | 2020-10-23 | 北京生物制品研究所有限责任公司 | 铝佐剂吸附型新型冠状病毒灭活疫苗中抗原的解离方法 |
CN111812313B (zh) * | 2020-06-22 | 2021-10-08 | 北京生物制品研究所有限责任公司 | 铝佐剂吸附型新型冠状病毒灭活疫苗中抗原的解离方法 |
CN111840540A (zh) * | 2020-08-04 | 2020-10-30 | 华北制药金坦生物技术股份有限公司 | 一种乙肝疫苗的解析方法 |
CN111840540B (zh) * | 2020-08-04 | 2023-09-22 | 华北制药金坦生物技术股份有限公司 | 一种乙肝疫苗的解析方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110554188A (zh) | 一种佐剂吸附组分疫苗含量的检测方法 | |
CN108226466B (zh) | 一种免疫层析试纸条及免疫层析检测方法 | |
CN112034186A (zh) | 一种基于生物素-链霉亲和素放大的糖化血红蛋白试剂盒及其制备方法 | |
CN111812336A (zh) | 用于检测冠状病毒抗体的检测试剂盒及其制备方法 | |
CN106018832B (zh) | 一种多价肺炎球菌结合疫苗各型特异性糖含量的检测方法 | |
CN111057150A (zh) | 一种乳胶微球及其应用以及糖化血红蛋白检测试剂盒 | |
CN102206270B (zh) | 石房蛤毒素人工抗原和抗体及其制备方法和应用 | |
CN106501511A (zh) | 一种重组Neu蛋白检测副猪嗜血杆菌抗体的间接ELISA方法及其试剂盒 | |
CN101046479B (zh) | 不含目标蛋白质人血清基体物质的制备方法 | |
CN111999505A (zh) | 检测抗链球菌溶血素o的试剂及其制备方法 | |
CN111239404B (zh) | 一种可以同时检测尿样本和血清样本中的视黄醇结合蛋白的检测试剂盒 | |
US9075049B2 (en) | Immunoassay method and reagent therefor | |
CN116008524A (zh) | 一种无蛋白通用型保护液及其制备方法和在真菌毒素定量检测试剂盒中的应用 | |
CN114137204B (zh) | 一种kl-6测定试剂盒及其制备与检测方法 | |
CN111239422A (zh) | 一种血清脂蛋白(a)胶乳增强比浊检测试剂盒 | |
EP2902783A1 (en) | Additive for measuring diluted sample in non-dilution-type immunochromatographic method reagent | |
CN108872609A (zh) | 一种用于检测犬细小病毒抗体的时间分辨荧光免疫试剂盒 | |
CN113075405A (zh) | 一种乙肝病毒表面抗原检测试剂盒及其制备方法 | |
CN111766381A (zh) | 一种基于胶乳免疫比浊法的测定试剂盒及其应用 | |
Keating et al. | Immunoassay for the determination of 7-hydroxycoumarin in serum using'real-time'biosensor analysis | |
CN114544527B (zh) | 一种涎液化糖链抗原kl-6测定试剂盒及其制备方法 | |
CN112495319B (zh) | 一种环瓜氨酸肽双微球偶联物及其制备方法与应用 | |
CN117405872A (zh) | 一种抗体纯化基质蛋白定量检测的试剂盒及其应用 | |
CN116413436A (zh) | 一种改进的人免疫球蛋白定量酶联免疫分析方法 | |
CN117031035A (zh) | 抗链球菌脱氧核糖核酸酶b抗体的检测试剂盒及方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20200108 Address after: 100176, No. 22, Tongji North Road, Beijing economic and Technological Development Zone, Beijing, Daxing District Applicant after: BEIJING ZHIFEI LVZHU BIOPHARMACEUTICAL Co.,Ltd. Applicant after: CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO.,LTD. Applicant after: ANHUI ZHIFEI LONGCOM BIOPHARMACEUTICAL Co.,Ltd. Address before: 100176 No. 22 Tongji North Road, Daxing District economic and Technological Development Zone, Beijing Applicant before: BEIJING ZHIFEI LVZHU BIOPHARMACEUTICAL Co.,Ltd. |
|
TA01 | Transfer of patent application right | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20191210 |
|
RJ01 | Rejection of invention patent application after publication |